NCT01040585撤回不适用
Cost Effectiveness Of Linezolid Vs Vancomycin In The Treatment Of Ventilator Acquired Pneumonia In Central America
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- Pfizer
- 主要终点
- The rate of resistance Empirical treatment days before specific therapy. Treatment days with Linezolid. Treatment days with Vancomycin.
研究概览
简要总结
The therapy with Linezolid (LIN) represents better cost-effectiveness vs. Vancomycin (VAN) for the treatment of nosocomial Pneumonia associate to ventilator (VAP).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Evidence of a legally acceptable representative signed and dated informed consent document indicating that him or her has been informed of all pertinent aspects of the study.
- •Adult (18 years old or older) men and women with confirm diagnosis of VAP treated on ICU with LIN or VAN; on the selected institutions.
排除标准
- •Adult men or women with nosocomial pneumonia not associated to a ventilator.
研究组 & 干预措施
Central America and the Caribbean
Panama, Costa Rica, Honduras, El Salvador and Nicaragua
干预措施: Linezolid (Drug)
结局指标
主要结局
The rate of resistance Empirical treatment days before specific therapy. Treatment days with Linezolid. Treatment days with Vancomycin.
时间窗: 4 months
Rate of renal failure.
时间窗: 4 months
Rate of healing with Linezolid.
时间窗: 4 months
Rate of healing with Vancomycin.
时间窗: 4 months
次要结局
- Hospitalization days average with VAN and Linezolid.(4 months)
- Variation of prices and values among the different institutions.(4 months)
- The average costs of each intervention.(4 months)
研究者
相似试验
已完成
不适用
Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized PatientsComplicated Skin and Structure InfectionNosocomial PneumoniaNCT01363271Pfizer7,260
已完成
4 期
Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)Skin/Soft Tissue InfectionsMethicillin Resistant Staphylococcus Aureus (MRSA)NCT00087490Pfizer1,077
已完成
4 期
Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)Methicillin Resistant Staphylococcus Aureus (MRSA)NCT00084266Pfizer1,225
已完成
3 期
Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive BacteriaBacterial InfectionsGram-Positive Bacterial InfectionsBacteremiaNCT00037050Pfizer739
进行中（未招募）
不适用
inezolid vs Vancomycin/Cefazolin in the treatment of hemodialysis patients with catheter-related gram-positive bloodstream infections - N/AEUCTR2004-005159-32-DEPfizer Pharma GmbH332